135 related articles for article (PubMed ID: 19891882)
1. Preexisting immunity to pandemic (H1N1) 2009.
Xing Z; Cardona CJ
Emerg Infect Dis; 2009 Nov; 15(11):1847-9. PubMed ID: 19891882
[No Abstract] [Full Text] [Related]
2. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China.
Chen H; Wang Y; Liu W; Zhang J; Dong B; Fan X; de Jong MD; Farrar J; Riley S; Smith GJ; Guan Y
Emerg Infect Dis; 2009 Nov; 15(11):1849-50. PubMed ID: 19891883
[No Abstract] [Full Text] [Related]
3. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
[TBL] [Abstract][Full Text] [Related]
4. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
van de Sandt CE; Kreijtz JH; de Mutsert G; Geelhoed-Mieras MM; Hillaire ML; Vogelzang-van Trierum SE; Osterhaus AD; Fouchier RA; Rimmelzwaan GF
J Virol; 2014 Feb; 88(3):1684-93. PubMed ID: 24257602
[TBL] [Abstract][Full Text] [Related]
5. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.
Krause JC; Tumpey TM; Huffman CJ; McGraw PA; Pearce MB; Tsibane T; Hai R; Basler CF; Crowe JE
J Virol; 2010 Mar; 84(6):3127-30. PubMed ID: 20042511
[TBL] [Abstract][Full Text] [Related]
7. Implications of the emergence of a novel H1 influenza virus.
Belshe RB
N Engl J Med; 2009 Jun; 360(25):2667-8. PubMed ID: 19423870
[No Abstract] [Full Text] [Related]
8. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.
Hung IF; To KK; Lee CK; Lin CK; Chan JF; Tse H; Cheng VC; Chen H; Ho PL; Tse CW; Ng TK; Que TL; Chan KH; Yuen KY
Clin Infect Dis; 2010 Aug; 51(3):274-9. PubMed ID: 20575664
[TBL] [Abstract][Full Text] [Related]
9. Swine flu pandemic. What's old is new: 1918 virus matches 2009 H1N1 strain.
Cohen J
Science; 2010 Mar; 327(5973):1563-4. PubMed ID: 20339037
[No Abstract] [Full Text] [Related]
10. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
[TBL] [Abstract][Full Text] [Related]
11. Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people.
Frobert E; Bouscambert-Duchamp M; Escuret V; Mundweiler S; Barthélémy M; Morfin F; Valette M; Gerdil C; Lina B; Ferraris O
Curr Microbiol; 2010 Jul; 61(1):25-8. PubMed ID: 20033691
[TBL] [Abstract][Full Text] [Related]
12. [Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].
Masalova OV; Chichev EV; Fediakina IT; Mukasheva EA; Klimova RR; Shchelkanov MIu; Burtseva EI; Ivanova VT; Kushch AA; L'vov DK
Vopr Virusol; 2014; 59(3):34-40. PubMed ID: 25335417
[TBL] [Abstract][Full Text] [Related]
13. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains.
Lee VJ; Tay JK; Chen MI; Phoon MC; Xie ML; Wu Y; Lee CX; Yap J; Sakharkar KR; Sakharkar MK; Lin RT; Cui L; Kelly PM; Leo YS; Tan YJ; Chow VT
Vaccine; 2010 Oct; 28(42):6852-7. PubMed ID: 20723626
[TBL] [Abstract][Full Text] [Related]
14. Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.
De Groot AS; McClaine E; Moise L; Martin W
Hum Vaccin; 2010 Feb; 6(2):161-63. PubMed ID: 20431339
[No Abstract] [Full Text] [Related]
15. Neutralizing antibodies against influenza A in pigs before and after the 2009 pandemic, Luxembourg.
Lutteke N; Sausy A; Black AP; Wildschutz F; Muller CP
Vet Microbiol; 2014 Feb; 169(1-2):96-101. PubMed ID: 24444864
[TBL] [Abstract][Full Text] [Related]
16. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.
Settembre EC; Dormitzer PR; Rappuoli R
J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014
[TBL] [Abstract][Full Text] [Related]
17. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers JA; Van De Velde LA; Allison KJ; Branum KC; Webby RJ; Flynn PM
Clin Infect Dis; 2010 Jun; 50(11):1487-92. PubMed ID: 20415539
[TBL] [Abstract][Full Text] [Related]
18. Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin.
Rudneva I; Ignatieva A; Timofeeva T; Shilov A; Kushch A; Masalova O; Klimova R; Bovin N; Mochalova L; Kaverin N
Virus Res; 2012 Jun; 166(1-2):61-7. PubMed ID: 22459010
[TBL] [Abstract][Full Text] [Related]
19. Prevention: Vaccine for all seasons.
Schlütter J
Nature; 2011 Nov; 480(7376):S6-8. PubMed ID: 22158298
[No Abstract] [Full Text] [Related]
20. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
